Kidney cancer, renal angiomyolipoma, etc.
Conditions
Interventions
Observation Group:None
Sponsors
Ankang Central Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form. 2. Age and gender are basically unrestricted. 3. According to the 2024 guidelines for urological male reproductive system diseases, the standardized diagnosis is: (1) T1 stage renal cell carcinoma; (2) There are anatomical or functional solitary kidney or bilateral kidney tumors; (3) Renal hamartoma; (4) Other benign renal tumors such as eosinophils and renal leiomyomas; (5) Other diseases that require partial nephrectomy; (6) Young patients, those with multiple renal tumors, and those with functional disorders that cause kidney damage (such as moderate to severe hypertension, diabetes, recurrent kidney stones, pathological obesity, etc.). 4. From 2025 to 2027, the patient was treated at Ankang Central Hospital.
Exclusion criteria
Exclusion criteria: 1. Locally advanced renal cell carcinoma; 2. The patient's health condition has deteriorated significantly; 3. The tumor is located in the kidney, which is not conducive to partial nephrectomy. 4. Tumors that are huge and difficult to separate and remove through laparoscopy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Warm Ischemia Time (WIT); | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical Duration, Blood Loss, Postoperative Tumor Recurrence Rate;Operational Convenience; | — |
Countries
China
Contacts
Public ContactXiong Bingjian
Ankang Central Hospital
Outcome results
None listed